Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Ixempra

(ik-SEM-pruh)
A drug used alone or with capecitabine to treat breast cancer that is locally advanced or has spread to other parts of the body and did not get better after treatment with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Ixempra blocks cell growth by stopping cell division and may kill cancer cells. It is a type of epothilone analog and a type of antimicrotubule agent. Also called BMS-247550 and ixabepilone.
Search NCI's Dictionary of Cancer Terms